Sumatriptan Succinate
Product Images NDC 68258-7114

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 68258-7114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-7114-xx (Ndc 68258 7114 Xx Caraco)

Label for sumatriptan succinate 50 mg tablets by Dispensing Solutions, Inc. The label includes dosing information, caution to keep out of children's reach, storage instructions, and notes that each tablet contains 70 mg sumatriptan succinate USP equivalent to 50 mg sumatriptan. The product is prescription only, with a sample lot number and expiration of 00-00 shown. The label also lists bulk source data and a barcode.*

FDA Label Image

Probability Of Response (Sumatriptan Fig1)

A line graph depicting the estimated probability of response over time in minutes from the initial dose, comparing placebo and sumatriptan succinate doses of 25 mg, 50 mg, and 100 mg. The probability of response increases over a 240-minute period for all doses, with 100 mg showing the highest response rate, followed by 50 mg, 25 mg, and placebo.*

FDA Label Image

Probability Of Remedication Of Response (Sumatriptan Fig2)

A line graph showing the estimated probability of remediation or rescue over time in hours from the initial dose for different doses of sumatriptan succinate (25 mg, 50 mg, 100 mg) compared to placebo. The vertical axis represents the probability percentage, and the horizontal axis shows time up to 24 hours, illustrating dose-dependent response trends.*

FDA Label Image

Chemical-structure (Sumatriptan Struct)

Chemical structure of sumatriptan succinate showing its molecular components, including an indole ring with a sulfonamide side group and a dimethylaminoethyl substituent, alongside the succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.